Skip to main content

USANS - February 2014

Just catching up on some recently published USAN statements.

USAN Research Code InChIKey (Parent) Drug Class Therapeutic class Target
asvasiran-sodium

ALN-RSV01

n/a RNAi therapeutic n/a
beclabuvir

BMS-791325

ZTTKEBYSXUCBSE-VSBZUFFNSA-N synthetic small molecule therapeutic HCV NS5B polymerase
benzhydrocodonebenzhydrocodone-hydrochloride
KP-201
VPMRSLWWUXNYRY-PJCFOSJUSA-N natural product derived small molecule therapeutic Opioid receptors
bradaniclinebradanicline-hydrochloride

TC-5619

OXKRFEWMSWPKKV-GHTZIAJQSA-N synthetic small molecule therapeutic alpha-7 nicotinic acetylcholine receptor
briciclibbriciclib-sodium

ON-014185

LXENKEWVEVKKGV-BQYQJAHWSA-N synthetic small molecule therapeutic n/a
ceritinib

NVP-LDK378-NX

VERWOWGGCGHDQE-UHFFFAOYSA-N synthetic small molecule therapeutic ALK
dasabuvir

ABT-333

NBRBXGKOEOGLOI-UHFFFAOYSA-N synthetic small molecule therapeutic HCV NS5B polymerase

defactinibdefactinib-hydrochloride

VS-6063

FWLMVFUGMHIOAA-UHFFFAOYSA-N synthetic small molecule therapeutic FAK
dianhydrogalactitol

VAL-083, NSC-1323313

AAFJXZWCNVJTMK-UHFFFAOYSA-N synthetic small molecule therapeutic DNA
dinutuximab
n/a
n/a monoclonal antibody therapeutic GD2
diridavumab

CR-6261

n/a monoclonal antibody therapeutic haemagglutinin
enceniclineencenicline-hydrochloride

EVP-6124

SSRDSYXGYPJKRR-ZDUSSCGKSA-N synthetic small molecule therapeutic alpha-7 nicotinic acetylcholine receptor
esuberaprostesuberaprost-sodium


APS-314d, BPS-314d

CTPOHARTNNSRSR-NOQAJONNSA-N synthetic small molecule therapeutic IP1 receptor
filociclovir


MBX-400

KMUNHOKTIVSFRA-KXFIGUGUSA-N synthetic small molecule therapeutic CMV DNA polymerase
fosdagrocorat

PF-04171327

n/a synthetic small molecule therapeutic GR
gedatolisib

PF-05212384, PKI-587

DWZAEMINVBZMHQ-UHFFFAOYSA-N synthetic small molecule therapeutic PI3K & mTOR
glasdegib

PF-04449913

SFNSLLSYNZWZQG-VQIMIIECSA-N synthetic small molecule therapeutic smoothened
indoximod
D-1MT
n/a natural product derived small molecule therapeutic IDO
latiglutenase

ALV-003

n/a enzyme therapeutic n/a
lulizumab-pegol BMS-931699

n/a monoclonal antibody therapeutic CD28
ombitasvir

ABT-267

PIDFDZJZLOTZTM-KHVQSSSXSA-N synthetic small molecule therapeutic HCV NS5a
omega-3-carboxylic-acids
n/a
n/a natural product derived small molecule therapeutic n/a
peficitinib

ASP-015K

DREIJXJRTLTGJC-UHFFFAOYSA-N synthetic small molecule therapeutic JAK
pegargiminase
n/a
n/a enzyme therapeutic n/a
pembrolizumab
n/a
n/a monoclonal antibody therapeutic Programmed cell death 1 (PDCD1)
polmacoxib

CG-100649

IJWPAFMIFNSIGD-UHFFFAOYSA-N synthetic small molecule therapeutic COX-2
sarolaner

PF-6450567

FLEFKKUZMDEUIP-QFIPXVFZSA-N synthetic small molecule therapeutic n/a
transcrocetinate-sodium
n/a
n/a natural product derived small molecule radiation sensitizer n/a
uprosertib

GSK-2141795C

AXTAPYRUEKNRBA-JTQLQIEISA-N synthetic small molecule therapeutic AKT1
venetoclax

ABT-199

LQBVNQSMGBZMKD-UHFFFAOYSA-N synthetic small molecule therapeutic BCL-2

Comments

Popular posts from this blog

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

LSH-based similarity search in MongoDB is faster than postgres cartridge.

TL;DR: In his excellent blog post , Matt Swain described the implementation of compound similarity searches in MongoDB . Unfortunately, Matt's approach had suboptimal ( polynomial ) time complexity with respect to decreasing similarity thresholds, which renders unsuitable for production environments. In this article, we improve on the method by enhancing it with Locality Sensitive Hashing algorithm, which significantly reduces query time and outperforms RDKit PostgreSQL cartridge . myChEMBL 21 - NoSQL edition    Given that NoSQL technologies applied to computational chemistry and cheminformatics are gaining traction and popularity, we decided to include a taster in future myChEMBL releases. Two especially appealing technologies are Neo4j and MongoDB . The former is a graph database and the latter is a BSON document storage. We would like to provide IPython notebook -based tutorials explaining how to use this software to deal with common cheminformatics p

Multi-task neural network on ChEMBL with PyTorch 1.0 and RDKit

  Update: KNIME protocol with the model available thanks to Greg Landrum. Update: New code to train the model and ONNX exported trained models available in github . The use and application of multi-task neural networks is growing rapidly in cheminformatics and drug discovery. Examples can be found in the following publications: - Deep Learning as an Opportunity in VirtualScreening - Massively Multitask Networks for Drug Discovery - Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set But what is a multi-task neural network? In short, it's a kind of neural network architecture that can optimise multiple classification/regression problems at the same time while taking advantage of their shared description. This blogpost gives a great overview of their architecture. All networks in references above implement the hard parameter sharing approach. So, having a set of activities relating targets and molecules we can tra

Using ChEMBL activity comments

We’re sometimes asked what the ‘activity_comments’ in the ChEMBL database mean. In this Blog post, we’ll use aspirin as an example to explain some of the more common activity comments. First, let’s review the bioactivity data included in ChEMBL. We extract bioactivity data directly from   seven core medicinal chemistry journals . Some common activity types, such as IC50s, are standardised  to allow broad comparisons across assays; the standardised data can be found in the  standard_value ,  standard_relation  and  standard_units  fields. Original data is retained in the database downloads in the  value ,  relation  and  units  fields. However, we extract all data from a publication including non-numerical bioactivity and ADME data. In these cases, the activity comments may be populated during the ChEMBL extraction-curation process  in order to capture the author's  overall  conclusions . Similarly, for deposited datasets and subsets of other databases (e.g. DrugMatrix, PubChem), th